For my 86‑year‑old woman: among female inpatients 81–91 with T2DM and heart failure, show prevalence (%) and absolute pp difference for oral antidiabetic classes (metformin, sulfonylurea, DPP4, SGLT2, TZD) first 72h vs final 48h.
